| NCT ID | NCT05755451 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Condition | Muscular Atrophy, Spinal |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2018-06-21 |
| Primary Completion | 2033-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2018-06-21 with a primary completion date of 2033-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is an investigator initiated observational study with the aim to record several aspects of function, care and adverse events in a large cohort of SMA patients followed longitudinally by using a structured academic disease registry.
Eligibility Criteria
Inclusion Criteria: all patients Exclusion Criteria: if enrolled in clinical trials
Contact & Investigator
Eugenio Mercuri, MD
PRINCIPAL INVESTIGATOR
F Policlinico Gemelli IRCCS
Frequently Asked Questions
Who can join the NCT05755451 clinical trial?
This trial is open to participants of all sexes, studying Muscular Atrophy, Spinal. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05755451 currently recruiting?
Yes, NCT05755451 is actively recruiting participants. Contact the research team at eugeniomaria.mercuri@policlinicogemelli.it for enrollment information.
Where is the NCT05755451 trial being conducted?
This trial is being conducted at Genova, Italy, Messina, Italy, Milan, Italy, Rome, Italy and 1 additional location.
Who is sponsoring the NCT05755451 clinical trial?
NCT05755451 is sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS. The principal investigator is Eugenio Mercuri, MD at F Policlinico Gemelli IRCCS. The trial plans to enroll 1,200 participants.